Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-29 Option Award | 2024-01-31 4:56 pm | N/A 2034-01-29 | Cyclacel Pharmaceuticals Inc. | CYCC | SCHWARTZ BRIAN Interim Chief Medical Officer | 12,500 | $0 | 27,705 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-03 4:55 pm | 2024-06-30 2033-06-30 | Cyclacel Pharmaceuticals Inc. | CYCC | SCHWARTZ BRIAN Director | 63,657 | $0 | 83,040 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-16 8:32 pm | N/A 2032-06-16 | INFINITY PHARMACEUTICALS INC. | INFI | SCHWARTZ BRIAN Director | 45,000 | $0 | 75,919 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-16 8:32 pm | N/A N/A | INFINITY PHARMACEUTICALS INC. | INFI | SCHWARTZ BRIAN Director | 30,919 | $0.679 | 75,919 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 4:11 pm | 2023-06-14 2032-06-14 | Cyclacel Pharmaceuticals Inc. | CYCC | SCHWARTZ BRIAN Director | 47,467 | $0 | 51,028 (Direct) | View |
| 2021-09-07 Option Award | 2021-09-10 12:35 pm | N/A 2031-09-07 | INFINITY PHARMACEUTICALS INC. | INFI | SCHWARTZ BRIAN Director | 60,000 | $0 | 60,000 (Direct) | View |
Ownership | 2021-09-10 12:30 pm | N/A 2030-05-15 | INFINITY PHARMACEUTICALS INC. | INFI | SCHWARTZ BRIAN Director | 0 | $0 | 116,250 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-17 4:07 pm | 2022-06-15 2031-06-15 | Cyclacel Pharmaceuticals Inc. | CYCC | SCHWARTZ BRIAN Director | 8,309 | $0 | 17,805 (Direct) | View |
| 2020-12-17 Option Award | 2020-12-21 4:48 pm | 2021-12-17 2030-12-17 | Cyclacel Pharmaceuticals Inc. | CYCC | SCHWARTZ BRIAN Director | 5,200 | $0 | 5,200 (Direct) | View |
Ownership | 2020-03-09 11:46 am | N/A N/A | LifeSci Acquisition Corp. | LSAC | SCHWARTZ BRIAN Director | 0 | $0 | 6,000 (Direct) | View |
| 2020-01-16 Disposition | 2020-01-16 3:55 pm | N/A 2025-01-20 | ARQULE INC | ARQL | SCHWARTZ BRIAN See Remarks | 1,452,404 | $0 | 0 (Direct) | View |
| 2020-01-16 Equity Swap | 2020-01-16 3:55 pm | N/A N/A | ARQULE INC | ARQL | SCHWARTZ BRIAN See Remarks | 289,838 | $20 | 0 (Direct) | View |
| 2019-12-18 Tax Withholding | 2019-12-20 4:08 pm | N/A N/A | ARQULE INC | ARQL | SCHWARTZ BRIAN Chief Medical Officer | 178,495 | $20.11 | 289,838 (Direct) | View |
| 2019-12-18 Exercise | 2019-12-20 4:08 pm | N/A N/A | ARQULE INC | ARQL | SCHWARTZ BRIAN Chief Medical Officer | 64,124 | $2.51 | 289,838 (Direct) | View |
| 2019-12-18 Exercise | 2019-12-20 4:08 pm | N/A N/A | ARQULE INC | ARQL | SCHWARTZ BRIAN Chief Medical Officer | 90,000 | $3.42 | 289,838 (Direct) | View |
| 2019-12-18 Exercise | 2019-12-20 4:08 pm | N/A N/A | ARQULE INC | ARQL | SCHWARTZ BRIAN Chief Medical Officer | 96,922 | $7.95 | 289,838 (Direct) | View |
| 2019-12-18 Exercise | 2019-12-20 4:08 pm | N/A N/A | ARQULE INC | ARQL | SCHWARTZ BRIAN Chief Medical Officer | 100,000 | $1.79 | 289,838 (Direct) | View |
| 2019-12-18 Exercise | 2019-12-20 4:08 pm | 2014-01-21 2020-01-21 | ARQULE INC | ARQL | SCHWARTZ BRIAN Chief Medical Officer | 351,046 | $0 | 289,838 (Direct) | View |